StockData
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. (RDHL) stock

RDHLNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 0/30
$0.35−0.01 (-2.91%)

Close on Nov 17, 2026Market cap $1.78MP/E –Yield –

RedHill Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

RedHill Biopharma's market cap was $1.16M on Nov 11, 2026, against $1.48M a year earlier. Over the last 5 years it ranged from $686.40K to $117.25M, with a median of $2.49M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.16M-8.9%
2025Dec 31, 2025$1.27M-21.1%
2024Dec 31, 2024$1.61M-28.5%
2023Dec 29, 2023$2.25M-65.5%
2022Dec 30, 2022$6.53M-93.1%
2021Dec 31, 2021$93.98M-60.8%
2020Dec 31, 2020$239.91M+71.0%
2019Dec 31, 2019$140.34M+43.2%
2018Dec 31, 2018$98.00M+48.0%
2017Dec 29, 2017$66.21M-43.3%
2016Dec 30, 2016$116.85M–

More RedHill Biopharma figures

See a number that looks wrong?